These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32803132)

  • 1. How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic.
    Rossi D; Shadman M; Condoluci A; Brown JR; Byrd JC; Gaidano G; Hallek M; Hillmen P; Mato A; Montserrat E; Ghia P
    Hemasphere; 2020 Aug; 4(4):e432. PubMed ID: 32803132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
    Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
    Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with chronic lymphocytic leukemia during the SARS-CoV-2 pandemic.
    Mihaila RG
    Oncol Lett; 2021 Aug; 22(2):636. PubMed ID: 34295383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
    Langerbeins P; Eichhorst B
    Acta Haematol; 2021; 144(5):508-518. PubMed ID: 33631756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.
    Fiorcari S; Atene CG; Maffei R; Mesini N; Debbia G; Colasante C; Pozzi S; Barbieri E; Maccaferri M; Leonardi G; Potenza L; Luppi M; Marasca R
    Hematol Oncol; 2023 Feb; 41(1):120-127. PubMed ID: 36156278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.
    Puła B; Pruszczyk K; Pietrusza E; Morawska M; Piszczek W; Kalicińska E; Szeremet A; Tryc-Szponder J; Wąsik-Szczepanek E; Drozd-Sokołowska J; Krzemień H; Rejus A; Gajewska M; Wiśniewski K; Wysocki M; Majeranowski A; Paszkiewicz-Kozik E; Steckiewicz P; Szukalski Ł; Bołkun Ł; Długosz-Danecka M; Giannopoulos K; Jamroziak K; Lech-Marańda E; Hus I
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EXPRESSION OF IMMUNOGLOBULIN SEQUENCES HOMOLOGOUS TO ANTI-SARS-CoV-2 ANTIBODIES AND HIV IN CHRONIC LYMPHOCYTIC LEUKEMIA CASES.
    Abramenko I; Bilous N; Chumak A; Martina Z; Dyagil I; Bazyka D
    Exp Oncol; 2022 Nov; 44(3):208-212. PubMed ID: 36325706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
    Qin K; Honjo K; Sherrill-Mix S; Liu W; Stoltz RM; Oman AK; Hall LA; Li R; Sterrett S; Frederick ER; Lancaster JR; Narkhede M; Mehta A; Ogunsile FJ; Patel RB; Ketas TJ; Cruz Portillo VM; Cupo A; Larimer BM; Bansal A; Goepfert PA; Hahn BH; Davis RS
    PLoS Med; 2023 Jun; 20(6):e1004157. PubMed ID: 37384638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Chronic Lymphocytic Leukemia During Admission for COVID-19: Cause or Coincidence?
    Saluja P; Gautam N; Amisha F; Safar M; Bartter T
    Cureus; 2022 Mar; 14(3):e23470. PubMed ID: 35494899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study.
    Doukas PG; St Pierre F; Karmali R; Mi X; Boyer J; Nieves M; Ison MG; Winter JN; Gordon LI; Ma S
    Oncologist; 2023 Oct; 28(10):e930-e941. PubMed ID: 37141401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Omicron Variant in Patients With Chronic Lymphocytic Leukemia: Case Series.
    Khamees I; Ali EA; Malkawi L; Rozi W; Yassin MA
    Cureus; 2022 Nov; 14(11):e32041. PubMed ID: 36600852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic.
    Sehn LH; Kuruvilla P; Christofides A; Stakiw J
    Curr Oncol; 2020 Jun; 27(3):e332-e335. PubMed ID: 32669941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.
    Zaleska J; Kwasnik P; Paziewska M; Purkot J; Szabelak A; Jurek M; Masny N; Dziatkiewicz I; Pronobis-Szczylik B; Piebiak A; Szymczyk A; Jarosz-Chudzik K; Bolkun L; Kozlowska K; Piszcz J; Subocz E; Halka J; Bator M; Kalicinska E; Wrobel T; Usnarska-Zubkiewicz L; Rybka J; Deren-Wagemann I; Szyca-Smieszniak M; Dybko J; Hus I; Pula B; Cichocka E; Rymko M; Zdunczyk D; Ziarkiewicz M; Basak GW; Bullinger L; Giannopoulos K
    Int J Cancer; 2023 Feb; 152(4):705-712. PubMed ID: 35830214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
    Mato AR; Roeker LE; Lamanna N; Allan JN; Leslie L; Pagel JM; Patel K; Osterborg A; Wojenski D; Kamdar M; Huntington SF; Davids MS; Brown JR; Antic D; Jacobs R; Ahn IE; Pu J; Isaac KM; Barr PM; Ujjani CS; Geyer MB; Berman E; Zelenetz AD; Malakhov N; Furman RR; Koropsak M; Bailey N; Hanson L; Perini GF; Ma S; Ryan CE; Wiestner A; Portell CA; Shadman M; Chong EA; Brander DM; Sundaram S; Seddon AN; Seymour E; Patel M; Martinez-Calle N; Munir T; Walewska R; Broom A; Walter H; El-Sharkawi D; Parry H; Wilson MR; Patten PEM; Hernández-Rivas JÁ; Miras F; Fernández Escalada N; Ghione P; Nabhan C; Lebowitz S; Bhavsar E; López-Jiménez J; Naya D; Garcia-Marco JA; Skånland SS; Cordoba R; Eyre TA
    Blood; 2020 Sep; 136(10):1134-1143. PubMed ID: 32688395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.
    Mauro FR; Giannarelli D; Galluzzo CM; Visentin A; Frustaci AM; Sportoletti P; Vitale C; Reda G; Gentile M; Levato L; Murru R; Armiento D; Molinari MC; Proietti G; Pepe S; De Falco F; Mattiello V; Barabino L; Amici R; Coscia M; Tedeschi A; Girmenia C; Trentin L; Baroncelli S
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
    Merli M; Ferrarini I; Merli F; Busca A; Mina R; Falini B; Bruna R; Cairoli R; Marchetti M; Romano A; Cavo M; Arcaini L; Trentin L; Cattaneo C; Derenzini E; Fracchiolla NS; Marchesi F; Scattolin A; Billio A; Bocchia M; Massaia M; Gambacorti-Passerini C; Mauro FR; Gentile M; Mohamed S; Della Porta MG; Coviello E; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Gherlinzoni F; Pagano L; Guidetti A; Bertù L; Corradini P; Passamonti F; Visco C
    Hematol Oncol; 2023 Feb; 41(1):128-138. PubMed ID: 36265128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
    Scarfò L; Chatzikonstantinou T; Rigolin GM; Quaresmini G; Motta M; Vitale C; Garcia-Marco JA; Hernández-Rivas JÁ; Mirás F; Baile M; Marquet J; Niemann CU; Reda G; Munir T; Gimeno E; Marchetti M; Quaglia FM; Varettoni M; Delgado J; Iyengar S; Janssens A; Marasca R; Ferrari A; Cuéllar-García C; Itchaki G; Špaček M; De Paoli L; Laurenti L; Levin MD; Lista E; Mauro FR; Šimkovič M; Van Der Spek E; Vandenberghe E; Trentin L; Wasik-Szczepanek E; Ruchlemer R; Bron D; De Paolis MR; Del Poeta G; Farina L; Foglietta M; Gentile M; Herishanu Y; Herold T; Jaksic O; Kater AP; Kersting S; Malerba L; Orsucci L; Popov VM; Sportoletti P; Yassin M; Pocali B; Barna G; Chiarenza A; Dos Santos G; Nikitin E; Andres M; Dimou M; Doubek M; Enrico A; Hakobyan Y; Kalashnikova O; Ortiz Pareja M; Papaioannou M; Rossi D; Shah N; Shrestha A; Stanca O; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Coscia M; Stamatopoulos K; Rossi G; Rambaldi A; Montserrat E; Foà R; Cuneo A; Ghia P
    Leukemia; 2020 Sep; 34(9):2354-2363. PubMed ID: 32647324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges.
    Roosta Y; Behzadi F; Askari E; Raeisi M; Danandeh Mehr A; Nouri-Vaskeh M
    Leuk Res Rep; 2021; 15():100239. PubMed ID: 33747763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era.
    Niemann CU; da Cunha-Bang C; Helleberg M; Ostrowski SR; Brieghel C
    Blood; 2022 Aug; 140(5):445-450. PubMed ID: 35588468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemia.
    Molica S; Tam C; Polliack A
    Hematol Oncol; 2022 Aug; 40(3):313-319. PubMed ID: 35304771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.